Startup Atlas · Healthcare

Laurus Labs Ltd Sector Top 20

$44.69 MnTotal funding (tracked)
1Funding rounds
1 Dec 2016Last round
Publicly listed · NSE:LAURUSLABS
₹2,005.10 -0.64% BSE, as of 22 Sep 26 | 16:01

Valuation

P/E71.96
P/E · TTM123.73
P/B19.56

Returns

ROE15.17%
ROCE16.08%

Per share

EPS27.86
Book value102.14

Growth · year on year

Sales+16.72%
Profit+94.66%

Ownership

Promoter holding27.47%

Price and ratios are compiled from the exchange and third-party market data, cached and refreshed through the day — they are not Atlas facts and are not investment advice. Where a ratio is computed on more than one basis (for example standalone versus trailing-twelve-month), each is shown separately rather than averaged into a single number.

56/100
Mixed Atlas Score — computed from 7 published figures
How this score is calculated
Measure Value Scores Source
P/E
What the market pays for each rupee of earnings. Lower is cheaper — but a low P/E can also mean the market expects earnings to fall.
Computed on a different basis this reads 123.73, which would score 0/100. Scored on the figure shown.
71.96 0/100 BSE
P/B
Price against book value. Most meaningful for banks and asset-heavy businesses; software and consumer brands trade high here for good reasons.
19.56 0/100 Market data
ROE
Return on equity — profit generated per rupee of shareholder capital. Sustained high ROE is the clearest single marker of a good business.
15.17 75/100 Market data
ROCE
Return on capital employed — the same idea including debt, so it is harder to flatter with leverage.
16.08 75/100 Market data
Profit growth
Year-on-year growth in profit. Weighted above sales growth because profitable growth is the harder thing to do.
94.66 100/100 Market data
Sales growth
Year-on-year growth in revenue.
16.72 75/100 Market data
Promoter holding
How much of the company its founders and controlling group still own. Higher usually means their money moves with yours.
27.47 50/100 Market data

The Atlas Score is our own arithmetic on the published figures above — nothing is hidden and nothing is bought in. It weighs quality and growth at 30% each, valuation at 25% and ownership at 15%, scoring each measure against fixed bands. Growth blends third-party market data with the fiscal-year figures we file and cite ourselves, so a company we have researched more deeply scores on richer evidence. A measure we could not fetch is left out of the average rather than counted as a zero. It is a summary of the numbers, not a recommendation, not a price target, and not advice about your circumstances.

View Laurus Labs Ltd's live share price on Google Finance ↗

Laurus Labs Ltd: Funding Rounds

Date Round Amount Investors Source
Dec 2016 ~ IPO ₹299.71 Cr fresh issue source

News on Laurus Labs Ltd

No coverage of Laurus Labs Ltd linked yet.

L Litmus · by Lapaas

Got an idea like this one? Validate it with the same 9-block framework, free.

Start Free Validation

FAQs on Laurus Labs Ltd

How much funding has Laurus Labs Ltd raised?

Laurus Labs Ltd has raised $44.69 Mn across 1 tracked funding round(s), most recently on 2016-12-01. Figures are compiled from cited public sources.

Sources & corrections. Every fact on this page is compiled from cited public sources — follow the "source" links beside each entry. Profile sources: www.bseindia.com · Last verified 23 Oct 2026. · Report a correction